Pfiz­er prunes three drugs from its pipeline; Astel­las in-li­cens­es ear drug

• Pfiz­er’s lat­est pipeline up­date comes with a no­tice of three mid­night pro­gram ex­e­cu­tions. The phar­ma gi­ant has pruned three drugs from its sub­stan­tial …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.